Oracea Doxycycline 40mg Modified-Release Capsules from Canada
Oracea brand 40mg doxycycline capsules with modified-release for anti-inflammatory treatment of rosacea, not antibacterial dosing. Still under HTS 3004.20.00.65 as it contains doxycycline salts in measured retail doses for therapeutic use.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include bioequivalence data for modified-release formulations
• Label as sub-antimicrobial dose if applicable to match therapeutic claims
• Ensure packaging prevents moisture degradation common in doxycycline